Has Aron Chary, MD received payments from drug or device companies?

Yes. Drug and device makers reported $219,039 in general payments to Aron Chary, MD across 242 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aron Chary, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aron Chary, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aron Chary, MD

Vascular & Interventional Radiology · Germantown, TNNPI 1316181662

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $179,894 of the $219,039 with a category attached, or 82.1%. Boston Scientific accounts for 94.1% of it on its own, with 18 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$219,039in general payments, 2019–2025

Across 242 payments — averaging $905.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$206K
Siemens Medical Solutions USA, Inc.$11K
Medtronic$690
Sirtex Medical Inc$558
Inari Medical, Inc.$221
Stryker$176
plus $486 from 13 others

What the payments were for

Consulting fees$20,5859%
Speaking & faculty fees$179,89482%
Travel & lodging$12,9526%
Food & beverage$5,6073%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	175	$206,097
Siemens Medical Solutions USA, Inc.	14	$10,811
Medtronic(3 entities)	17	$690
Sirtex Medical Inc	6	$558
Inari Medical, Inc.	3	$221
Stryker	7	$176
Terumo Medical Corporation	1	$122
Cordis US CORP.	3	$80
Argon Medical Devices, Inc.	4	$57
Qapel Medical Inc	2	$45
Angiodynamics, Inc.	2	$40
Silk Road Medical, Inc.	1	$29
Philips North America LLC	1	$27
Nevro Corp.	1	$17
Trisalus Life Sciences, Inc.	1	$17
Cashflow Solutions, LLC	1	$14
Mozarc Medical US LLC	1	$14
Bard Peripheral Vascular, Inc.	1	$14
Triad Life Sciences Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TheraSphere Y90 Glass Microspheres 10 GBq$81,224
GENERAL - IO ABLATION$47,795
GENERAL PAIN MANAGEMENT$20,030
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$17,395
GENERAL - THERAPIES$14,349
General - Interventional Oncology$6,000
THERASPHERE$3,622
ICEfx Cryoablation System$1,146
SIR-Spheres Microspheres$446
FLOWTRIEVER CATHETER, S$358
Varian CRYOCARE TOUCH System$142
Concerto$124
Navicross$122
Azur CX Detachable$122
CONCERTOTM$120
Emprint$107

How this compares

$219,039 in reported general payments places this provider in the 95th percentile of 76 vascular & interventional radiology providers in Tennessee.

See all vascular & interventional radiology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$929,121

Medicare patients

635

Services billed

3,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Moxifloxacin Hcl	26	$1,048
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	49	$254
Ondansetron Hcl	43	$217
Methylprednisolone	27	$147

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Germantown

Joel PerchikGermantown$37K
David CohenGermantown$18K
John BraunGermantown$10K
Emilio CazanoGermantown$8K
William WoodruffGermantown$3K
Chika ObeleGermantown$2K
Scott BaumGermantown$1K
Britton WoodwardKnoxville$1.6M
Samdeep MouliNashville$217K
Reed OmaryNashville$66K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →